Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1993-02-18
1995-02-14
Moezie, F. T.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514800, 530328, 424439, 424445, 930 10, 930130, A61K 3702, A61K 3743
Patent
active
053896130
ABSTRACT:
A novel method of treating prostate adenocarcinoma, prostate benign hypertrophia, endometriosis, dysmenorrhea, hirsuitism, hormono-dependant mammary tumors, treatment and prevention of precocious puberty, induction of a retardation of the appearance of puberty and treatment of acne of mammals comprising administering to warm-blooded animals an effective amount of a peptide of the formula
REFERENCES:
patent: 4472382 (1983-02-01), Labrie
patent: 4728640 (1986-08-01), Labrie
patent: 4743589 (1984-06-01), Labrie
patent: 4745102 (1986-10-01), Labrie
patent: 4851386 (1987-11-01), Labrie
patent: 5189021 (1990-10-01), Labrie
Goodman and Gilman's The Pharmaceutical Basis of Therapeutics, 8th ed., Pergamon Press, N.Y. 1990, pp. 1427-1428.
Labrie Fernand
Raynaud Jean-Pierre
Moezie F. T.
Roussel Uclaf
Shering Corporation
LandOfFree
Method of treating prostate adenocarcinoma, prostate benign hype does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating prostate adenocarcinoma, prostate benign hype, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating prostate adenocarcinoma, prostate benign hype will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-288014